Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, November 15, 2021
[ Mon, Nov 15th 2021
] - WOPRAI
Fri, November 12, 2021
[ Fri, Nov 12th 2021
] - WOPRAI
[ Fri, Nov 12th 2021
] - WOPRAI
[ Fri, Nov 12th 2021
] - WOPRAI
[ Fri, Nov 12th 2021
] - WOPRAI
[ Fri, Nov 12th 2021
] - WOPRAI
[ Fri, Nov 12th 2021
] - WOPRAI
[ Fri, Nov 12th 2021
] - WOPRAI
[ Fri, Nov 12th 2021
] - WOPRAI
[ Fri, Nov 12th 2021
] - WOPRAI
[ Fri, Nov 12th 2021
] - WOPRAI
[ Fri, Nov 12th 2021
] - WOPRAI
[ Fri, Nov 12th 2021
] - WOPRAI
[ Fri, Nov 12th 2021
] - WOPRAI
[ Fri, Nov 12th 2021
] - WOPRAI
[ Fri, Nov 12th 2021
] - WOPRAI
[ Fri, Nov 12th 2021
] - WOPRAI
[ Fri, Nov 12th 2021
] - WOPRAI
[ Fri, Nov 12th 2021
] - WOPRAI
[ Fri, Nov 12th 2021
] - WOPRAI
[ Fri, Nov 12th 2021
] - WOPRAI
[ Fri, Nov 12th 2021
] - WOPRAI
[ Fri, Nov 12th 2021
] - WOPRAI
[ Fri, Nov 12th 2021
] - WOPRAI
[ Fri, Nov 12th 2021
] - WOPRAI
[ Fri, Nov 12th 2021
] - WOPRAI
[ Fri, Nov 12th 2021
] - WOPRAI
[ Fri, Nov 12th 2021
] - WOPRAI
[ Fri, Nov 12th 2021
] - WOPRAI
[ Fri, Nov 12th 2021
] - WOPRAI
Edward Nash Maintained (VRNA) at Strong Buy with Increased Target to $23 on, Nov 12th, 2021
Edward Nash of Canaccord Genuity, Maintained "Verona Pharma plc" (VRNA) at Strong Buy with Increased Target from $18 to $23 on, Nov 12th, 2021.
Edward has made no other calls on VRNA in the last 4 months.
There is 1 other peer that has a rating on VRNA. Out of the 1 peers that are also analyzing VRNA, 0 agree with Edward's Rating of Hold.
This is the rating of the analyst that currently disagrees with Edward
- Raghuram Selvaraju of "HC Wainwright & Co." Initiated at Strong Buy and Held Target at $25 on, Monday, September 13th, 2021
